{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:25:49Z","timestamp":1790130349777,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ophtha.2023.11.022","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T22:16:35Z","timestamp":1700777795000},"page":"595-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Efficacy and Safety of Standard versus Soft Topical Steroids after Cataract Surgery"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-3524","authenticated-orcid":false,"given":"Dror Ben Ephraim","family":"Noyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-2011","authenticated-orcid":false,"given":"Clara C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mimouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1814-8316","authenticated-orcid":false,"given":"Margarita","family":"Safir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.11.022_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaophthalmol.2015.5322","article-title":"Geographic variation in the rate and timing of cataract surgery among US communities","volume":"134","author":"Kauh","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000464","article-title":"Cataract surgery practice patterns worldwide: a survey","volume":"6","author":"Rossi","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib3","first-page":"Cd010516","article-title":"Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery","volume":"7","author":"Juthani","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2023.11.022_bib4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ophtha.2014.04.035","article-title":"Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review","volume":"121","author":"Kessel","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.022_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2020.02.007","article-title":"Anti-inflammatory medication after cataract surgery and posterior capsular opacification","volume":"215","author":"Hecht","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/aos.15265","article-title":"Incidence of unplanned visits after cataract surgery in two large cohorts with different anti-inflammatory treatment protocols","volume":"101","author":"G\u00e4rdin","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib7","article-title":"Long-term risk of steroid-induced ocular hypertension\/glaucoma with topical prednisolone acetate 1% after Descemet stripping endothelial keratoplasty","author":"Price","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2023.11.022_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/ICO.0000000000000206","article-title":"Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after Descemet membrane endothelial keratoplasty","volume":"33","author":"Price","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2023.11.022_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.10.7.15","article-title":"Relationship between prolonged intraocular inflammation and macular edema after cataract surgery","volume":"10","author":"Aaronson","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib10","doi-asserted-by":"crossref","first-page":"e1061","DOI":"10.1111\/aos.15154","article-title":"Preventive treatment of allograft rejection after endothelial keratoplasty: a systematic review and meta-analysis","volume":"100","author":"Magnier","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib11","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2023.11.022_bib12","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2023.11.022_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2023"},{"key":"10.1016\/j.ophtha.2023.11.022_bib14","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A\u00a0simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2023.11.022_bib15","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/sim.4298","article-title":"Expressing findings from meta-analyses of continuous outcomes in terms of risks","volume":"30","author":"Anzures-Cabrera","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2023.11.022_bib16","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41433-020-0876-2","article-title":"Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin","volume":"34","author":"Tao","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2023.11.022_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/ejhpharm-2020-002447","article-title":"Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials","volume":"29","author":"Zhao","year":"2022","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.ophtha.2023.11.022_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/aos.13224","article-title":"Cross-linking in children with keratoconus: a systematic review and meta-analysis","volume":"95","author":"McAnena","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib19","first-page":"932","article-title":"Randomized-controlled study on anti-inflammation and safety of three drugs after Nd:YAG laser posterior capsulotomy","volume":"30","author":"L\u00fc","year":"2012","journal-title":"Zhonghua Shiyan Yanke Zazhi\/Chinese Journal of Experimental Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.022_bib20","article-title":"Controlled evaluation of fluorometholone acetate and loteprednol etabonate in the treatment of postoperative inflammation following cataract surgery","volume":"45","author":"Stewart","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.11.022_bib21","first-page":"234","article-title":"Comparison of the effect of loteprednol etabonate and prednisolone acetate on the intraocular pressure in uncomplicated phacoemulsification surgery","volume":"19","author":"Coban","year":"2010","journal-title":"Turk Klin J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0955-3681(14)80017-8","article-title":"The comparative effect of fluorometholone 0.1 % and prednisolone-acetate 1 % eye drops on the blood-aqueous barrier following cataract extraction and posterior chamber lens implantation. A randomized, controlled fluorophotometric study","volume":"4","author":"Diestelhorst","year":"1992","journal-title":"Eur J Implant Refract Surg"},{"key":"10.1016\/j.ophtha.2023.11.022_bib23","first-page":"1619","article-title":"Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin\/dexamethasone eye drops after cataract surgery","volume":"9","author":"Chen","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000346847","article-title":"Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification","volume":"229","author":"Wang","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2023.11.022_bib25","first-page":"143","article-title":"Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification","volume":"86","author":"Trinavarat","year":"2003","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.ophtha.2023.11.022_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/112067219700700204","article-title":"A\u00a0comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery","volume":"7","author":"van Endt","year":"1997","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2023.11.022_bib27","first-page":"1","article-title":"Compare the safety and efficacy of loteprednol etabonate 0.5% and prednisolone acetate 1% in the post operative inflammation following cataract extraction with intra ocular lens (IOL) implant","volume":"2","author":"Kaur","year":"2015","journal-title":"Annals of Applied Bio-Sciences"},{"key":"10.1016\/j.ophtha.2023.11.022_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/j.jcrs.0000000000000218","article-title":"Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children","volume":"46","author":"Vittitow","year":"2020","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2023.11.022_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcrs.2012.10.039","article-title":"Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery","volume":"39","author":"Lane","year":"2013","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2023.11.022_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10792-022-02426-y","article-title":"Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery","volume":"43","author":"Li","year":"2023","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","article-title":"Steroid-induced glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J\u00a0Curr Glaucoma Pract"},{"key":"10.1016\/j.ophtha.2023.11.022_bib32","doi-asserted-by":"crossref","first-page":"E820","DOI":"10.1208\/aapsj070479","article-title":"Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems","volume":"7","author":"Bodor","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.ophtha.2023.11.022_bib33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","article-title":"Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance","volume":"93","author":"Awan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/1120672119885050","article-title":"Risk of intraocular pressure elevation after topical steroids in children and adults: a systematic review","volume":"30","author":"Musleh","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcrs.2003.07.006","article-title":"Posterior capsule opacification after phacoemulsification in patients with postoperative steroidal and nonsteroidal treatment","volume":"30","author":"Zaczek","year":"2004","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2023.11.022_bib36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ajo.2015.07.032","article-title":"Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis","volume":"160","author":"Wielders","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.022_bib37","series-title":"Doing Meta-Analysis With R: A Hands-On Guide","author":"Harrer","year":"2021"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023008576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023008576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T08:16:07Z","timestamp":1713428167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023008576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0161642023008576"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.11.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy and Safety of Standard versus Soft Topical Steroids after Cataract Surgery","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}